Annual EBIT
-$1.11B$288.75M-35.00%
Summary
- Current Value
- As of today, ROIV annual EBIT is -$1.11B, down -35.00% on
- Historical Performance
- ROIV annual EBIT is up +8.09% over the past 3 years, and down -109.17% over the past 5 years
- All-Time High Comparison
- ROIV annual EBIT is currently -109.17% below its historical high of -$532.43M set on
- 3-Year Low Comparison
- ROIV annual EBIT is +8.09% above its 3-year low of -$1.21B reached on an earlier date
- Sector Comparison
- ROIV annual EBIT is higher than 0.59% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$1.11B | -35.0% | +8.1% | -109.2% | -48.8% | |
| Quarterly EBIT | -$306.23M | +10.4% | -9.1% | +43.4% | -271.2% | |
| TTM EBIT | -$1.15B | -17.1% | -22.9% | -112.7% | -1294.5% | |
| Price | $23.81 | +117.6% | +141.2% | +131.6% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $29.05M | -11.2% | -47.5% | -57.1% | +1150.1% | |
| Annual EPS | -$0.24 | -104.5% | +81.2% | -104.5% | +95.1% | |
| Annual EBITDA | -$1.11B | -35.9% | -21.5% | – | – | |
| Annual Net Income | -$729.76M | -116.0% | +21.0% | -28.4% | +9.9% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$824.93M | -35.0% | |
| 5Y | -$532.43M | N/A | -109.2% |
| All | -$532.43M | -109.2% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$1.21B | N/A | +8.1% |
| 5Y | -$1.21B | +8.1% | |
| All | -$1.21B | +8.1% |
EBIT History
| Year | Value | Change |
|---|---|---|
| -$1.11B | -35.0% | |
| -$824.93M | +23.4% | |
| -$1.08B | +11.1% | |
| -$1.21B | -13.2% |
| Year | Value | Change |
|---|---|---|
| -$1.07B | -101.1% | |
| -$532.43M | +28.9% | |
| -$748.49M | - |
FAQ
What is the current annual EBIT of ROIV?
As of today, ROIV annual EBIT is -$1.11B
What is 1-year change in ROIV annual EBIT?
ROIV annual EBIT is down -35.00% year-over-year
What is 3-year change in ROIV annual EBIT?
ROIV annual EBIT is up +8.09% over the past 3 years
How far is ROIV annual EBIT from its all-time high?
ROIV annual EBIT is currently -109.17% below its historical high of -$532.43M set on March 1, 2020
How does ROIV annual EBIT rank versus sector peers?
ROIV annual EBIT is higher than 0.59% of companies in Healthcare sector
When is ROIV next annual earnings release?
As of today, the next annual earnings release for ROIV has not been scheduled
Quarterly EBIT
-$306.23M$21.31M-7.48%
Summary
- Current Value
- As of today, ROIV quarterly EBIT is -$306.23M, down -7.48% on
- Historical Performance
- ROIV quarterly EBIT is up +10.38% year-over-year, and down -9.07% over the past 3 years
- All-Time High Comparison
- ROIV quarterly EBIT is currently -271.19% below its historical high of -$82.50M set on
- 3-Year Low Comparison
- ROIV quarterly EBIT is +10.38% above its 3-year low of -$341.71M reached on
- Sector Comparison
- ROIV quarterly EBIT is higher than 0.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | -$306.23M | -7.5% | +10.4% | -9.1% | +43.4% | |
| Annual EBIT | -$1.11B | – | -35.0% | +8.1% | -109.2% | |
| TTM EBIT | -$1.15B | +3.0% | -17.1% | -22.9% | -112.7% | |
| Price | $23.81 | +45.2% | +117.6% | +141.2% | +131.6% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.57M | -27.6% | -64.9% | -87.5% | -89.6% | |
| Quarterly EPS | -$0.17 | +49.2% | +46.7% | +60.0% | +92.7% | |
| Quarterly EBITDA | -$305.31M | -7.6% | +10.9% | -10.7% | +16.5% | |
| Quarterly Net Income | -$166.04M | +39.4% | +29.9% | +47.4% | +70.5% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$274.38M | N/A | -11.6% |
| 3Y | -$199.94M | -53.2% | |
| 5Y | -$82.50M | N/A | -271.2% |
| All | -$82.50M | -271.2% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$306.23M | at low | |
| 3Y | -$341.71M | +10.4% | |
| 5Y | -$684.43M | +55.3% | |
| All | -$684.43M | +55.3% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of ROIV?
As of today, ROIV quarterly EBIT is -$306.23M
What is ROIV quarterly EBIT most recent change?
ROIV quarterly EBIT was down -7.48% on September 30, 2025
What is 1-year change in ROIV quarterly EBIT?
ROIV quarterly EBIT is up +10.38% year-over-year
How far is ROIV quarterly EBIT from its all-time high?
ROIV quarterly EBIT is currently -271.19% below its historical high of -$82.50M set on March 1, 2020
How does ROIV quarterly EBIT rank versus sector peers?
ROIV quarterly EBIT is higher than 0.27% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
TTM EBIT
-$1.15B$35.48M+2.99%
Summary
- Current Value
- As of today, ROIV TTM EBIT is -$1.15B, up +2.99% on
- Historical Performance
- ROIV TTM EBIT is down -17.14% year-over-year, and down -22.92% over the past 3 years
- All-Time High Comparison
- ROIV TTM EBIT is currently -1294.53% below its historical high of -$82.50M set on
- 3-Year Low Comparison
- ROIV TTM EBIT is +2.99% above its 3-year low of -$1.19B reached on
- Sector Comparison
- ROIV TTM EBIT is higher than 0.45% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | -$1.15B | +3.0% | -17.1% | -22.9% | -112.7% | |
| Annual EBIT | -$1.11B | – | -35.0% | +8.1% | -109.2% | |
| Quarterly EBIT | -$306.23M | -7.5% | +10.4% | -9.1% | +43.4% | |
| Price | $23.81 | +45.2% | +117.6% | +141.2% | +131.6% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $20.33M | -12.5% | -45.1% | -59.7% | +34.2% | |
| TTM EPS | -$0.55 | +20.9% | -109.8% | +67.5% | +75.9% | |
| TTM EBITDA | -$1.15B | +3.2% | -17.6% | -23.4% | -213.2% | |
| TTM Net Income | -$901.27M | +7.3% | -118.9% | +28.9% | -60.0% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.04B | N/A | -11.1% |
| 3Y | -$840.35M | -36.9% | |
| 5Y | -$82.50M | N/A | -1294.5% |
| All | -$82.50M | -1294.5% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.19B | +3.0% | |
| 3Y | -$1.19B | +3.0% | |
| 5Y | -$1.63B | +29.2% | |
| All | -$1.63B | +29.2% |
TTM EBIT History
FAQ
What is the current TTM EBIT of ROIV?
As of today, ROIV TTM EBIT is -$1.15B
What is ROIV TTM EBIT most recent change?
ROIV TTM EBIT was up +2.99% on September 30, 2025
What is 1-year change in ROIV TTM EBIT?
ROIV TTM EBIT is down -17.14% year-over-year
How far is ROIV TTM EBIT from its all-time high?
ROIV TTM EBIT is currently -1294.53% below its historical high of -$82.50M set on March 1, 2020
How does ROIV TTM EBIT rank versus sector peers?
ROIV TTM EBIT is higher than 0.45% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
EBIT Formula
EBIT = Revenue − −
Data Sources & References
- ROIV Official Website roivant.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1635088/000163508825000016/0001635088-25-000016-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1635088/000114036125020715/0001140361-25-020715-index.htm
- ROIV Profile on Yahoo Finance finance.yahoo.com/quote/ROIV
- ROIV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/roiv